Cargando…

Vitiligo - Part 2 - classification, histopathology and treatment*

In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new classification protocol for the disease. The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichert Faria, Adriane, Tarlé, Roberto Gomes, Dellatorre, Gerson, Mira, Marcelo Távora, Silva de Castro, Caio Cesar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155957/
https://www.ncbi.nlm.nih.gov/pubmed/25184918
http://dx.doi.org/10.1590/abd1806-4841.20142717
_version_ 1782333661731880960
author Reichert Faria, Adriane
Tarlé, Roberto Gomes
Dellatorre, Gerson
Mira, Marcelo Távora
Silva de Castro, Caio Cesar
author_facet Reichert Faria, Adriane
Tarlé, Roberto Gomes
Dellatorre, Gerson
Mira, Marcelo Távora
Silva de Castro, Caio Cesar
author_sort Reichert Faria, Adriane
collection PubMed
description In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new classification protocol for the disease. The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes. Physical and pharmacological treatment strategies aim to control the autoimmune damage and stimulate melanocyte migration from the unaffected edges of lesions and the outer hair follicle root sheath to the affected skin; moreover, surgical treatments can be combined with topical and physical treatments.
format Online
Article
Text
id pubmed-4155957
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-41559572014-09-09 Vitiligo - Part 2 - classification, histopathology and treatment* Reichert Faria, Adriane Tarlé, Roberto Gomes Dellatorre, Gerson Mira, Marcelo Távora Silva de Castro, Caio Cesar An Bras Dermatol Review In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new classification protocol for the disease. The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes. Physical and pharmacological treatment strategies aim to control the autoimmune damage and stimulate melanocyte migration from the unaffected edges of lesions and the outer hair follicle root sheath to the affected skin; moreover, surgical treatments can be combined with topical and physical treatments. Sociedade Brasileira de Dermatologia 2014 /pmc/articles/PMC4155957/ /pubmed/25184918 http://dx.doi.org/10.1590/abd1806-4841.20142717 Text en ©2014 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Reichert Faria, Adriane
Tarlé, Roberto Gomes
Dellatorre, Gerson
Mira, Marcelo Távora
Silva de Castro, Caio Cesar
Vitiligo - Part 2 - classification, histopathology and treatment*
title Vitiligo - Part 2 - classification, histopathology and treatment*
title_full Vitiligo - Part 2 - classification, histopathology and treatment*
title_fullStr Vitiligo - Part 2 - classification, histopathology and treatment*
title_full_unstemmed Vitiligo - Part 2 - classification, histopathology and treatment*
title_short Vitiligo - Part 2 - classification, histopathology and treatment*
title_sort vitiligo - part 2 - classification, histopathology and treatment*
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155957/
https://www.ncbi.nlm.nih.gov/pubmed/25184918
http://dx.doi.org/10.1590/abd1806-4841.20142717
work_keys_str_mv AT reichertfariaadriane vitiligopart2classificationhistopathologyandtreatment
AT tarlerobertogomes vitiligopart2classificationhistopathologyandtreatment
AT dellatorregerson vitiligopart2classificationhistopathologyandtreatment
AT miramarcelotavora vitiligopart2classificationhistopathologyandtreatment
AT silvadecastrocaiocesar vitiligopart2classificationhistopathologyandtreatment